Leuprorelin acetate, a medicine approved in the U.S. for prostate cancer, may slow the progression of SMA type SBMA, ...
The cellular therapy landscape continues to evolve beyond hematologic malignancies, now making significant progress in solid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback